Home/ Stocks/ TNYA

Tenaya Therapeutics, Inc. Common Stock

TNYA XNAS

$0.73 +0.02 (+2.65%) ▲ 15-min delayed

Open

$0.73

High

$0.76

Low

$0.72

Volume

1.59M

Market Cap

$162.75M

About Tenaya Therapeutics, Inc. Common Stock

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 70 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$1.11M	$-43,393,000	$-0.20
Q1 2026	$225.0K	$-19,272,000	$-0.09
FY 2025	$0	$-90,597,000	$-0.59
Q3 2025	$0	$-20,275,000	$-0.12

Earnings & Analyst Ratings

Next Earnings: Mon, Nov 2, 2026

Calendar →

Related Market News

No specific coverage for TNYA yet. Check out our latest market news or earnings calendar.

Get TNYA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Tenaya Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.